Bioassociate is an Israeli company established in 2008 and operating in the life science arena. Bioassociate provides expertise-based consulting, research and analysis services to international life science companies and investment entities (investment banks, private and institutional investors). Visit our website at www.bioassociate.com.
Having recently started building a long term strategy for a dividend growth portfolio, I am interested in improving and learning better ways to identify and evaluate the future great dividend stocks.
I put a lot of faith in numbers and math, but where I need improvement is avoiding this garbage in and garbage out tendency and better understanding FCF valuations and projections.
SHIRE AbbVie MERGER GOING DOWN THE TUBE
Delaware Supreme Court to Hear Argument on When Stockholders Can Demand Records of Aborted Merger
Tomorrow, the Delaware Supreme Court will hear oral argument on an appeal of the decision of the Court of Chancery which denied a request by a stockholder for books and records, pursuant to DGCL Section 220, related to the aborted merger of AbbVie, Inc., a pharmaceutical spin-off of Abbott Labs, and Shire, a pharmaceutical company based in Ireland. If completed, the inversion would have had major tax benefits for AbbVie, but before the deal was completed, the Treasury Department enacted regulations to terminate the tax benefit from such an inversion. The net result was that AbbVie was required to pay a termination fee to Shire of $1.6 billion. The case is Southeastern Pennsylvania Transportation Authority v. AbbVie Inc., No. 239, 2015, oral argument scheduled (Del. Nov. 4, 2015). The Chancery decision relates to two affiliated cases styled: Se. Pa. Transp. Auth. v. AbbVie Inc., No. 10374; Rizzolo v. AbbVie Inc., No. 10408, 2015 WL 1753033 (Del. Ch. Apr. 15, 2015).
Next topic for discussion is SIRI please see attached link chart info provided by FRT
I'm using Adobe Send & Track. You can view my file in Adobe Document Cloud by clicking on the link below:
Next Interesting investment is Bank of America
Master in Applied Maths & Computer Science from Moscow State University. MA in Economics from New Economic School, Moscow, Russia. CFA Charterholder.
First 3 years - sell side research (first equity, then fixed income).
Next 3 years - buy side, equity & HFs (first analyst, then fund manager).
Ever since - Private Banking, all asset classes, fund selection, FoF manager, ETF strategies; some single stock mandates and M&A advisory (biotech/pharma, IT, resource juniors).
Renaissance Investment Management, HSBC, Raiffeisenbank Austria. Currently PM at Leon Multi-Family Office (Russia/Cyprus).
An elderly halfnerd living in Denmark which is a small country with 5 millions inhabitants, and own language (danish) and a queen.
Many people at my age (above seventy) use their pension on one armed bandits) . I am not much better, because I play the stock market. However I have more surplus from that, than playing one armed bandits. Have for the time beeing around 25 stocks in my portfolio. Some of them Apples.